Wanbury
WANBURYNSE

Wanbury

₹230.39-0.03 (0.01%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
222.00
Today’s high
234.00
52 week low
161.50
52 week high
329.70
Open price
226.98
Previous close
230.42
Live volume
58,855
Lower circuit
218.88
Upper circuit
241.90

Fundamentals

Market Cap
₹805Cr
ROE
51.51%
P/E Ratio(TTM)
18.73
EPS(TTM)
12.30
P/B Ratio
10.40
Dividend Yield
0.00%
Industry P/E
31.31
Book Value
22.16
Debt to Equity
2.98
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Wanbury Limited is a pharmaceutical company manufacturing Active Pharmaceutical Ingredients (APIs) and finished formulations, with a global presence.;
MD/CEO
NA
Founded in
1988
NSE symbol
WANBURY
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Retail And Others
55.93%
Promoters
43.07%
Foreign Institutions
0.99%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹704.40
+0.45 (0.06%)
L
    H
    4,025.7730.43.94
    ₹388.25
    -4.50 (1.15%)
    L
      H
      3,640.7240.624.99
      Aarti DrugsAARTIDRUGS
      ₹352.70
      +6.30 (1.82%)
      L
        H
        3,213.1615.872.19
        ₹288.60
        -0.10 (0.03%)
        L
          H
          2,905.6958.074.6
          Livesquawk
          Wanbury's Q3 EBITDA rose to ₹267M from ₹139M YoY, reflecting strong growth. Q3 EBITDA margin improved to 16.4% from 10.5% YoY, showcasing efficiency gains.
          Livesquawk
          Wanbury Limited launches four new anesthetic APIs at Tanuku facility. The initiative aims for ₹100 crore revenue by FY 2026-27, adding 15% to annual revenue.
          Livesquawk
          Wanbury's Q2 net profit surged to 152M rupees from 80M YoY. EBITDA rose to 257.8M rupees, margin improved to 16.11% from 12.41% YoY.
          2026
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks